3Crawford LV, Pim DC, Bulbrook R,et al.Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer[J].Int J Cancer,1982,30(2):403-408.
4Linzer DI, Levine AJ. Characterization of a 54K Dalton Cellular SV 40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells[J]. Cell,1979,17(1):43-52.
5Wunderlich H, Hindermann W, Huller M, et al. The correlation of p53 protein overexpression and p53 antibodies in serum of patients with transitional cell carcinoma of the urinary bladder[J]. Urol Int,2000,64(3):13-17.
6Kanaya N, Okuda M, Toyama N,et al. Detection of the anti-bodies in dogs with tumors[J]. J Vet Med Sci,2002,64(11):973-979.
7Sakai H, Okamoto E. Clinical importance of serum anti-p53 antibodies as tumor markers[J]. Rinsho Byori,2002,50(10):970-975.
8Hammel P, Leroy-Viard K,Chaumette MT,et al. Correlations between p53-protein accumulation ,serum antibodies and gene mutation in colorectal cancer[J]. Int J Cancer,1999,81(5):712-718.
9Guinee DG Jr,Travis WD, Travis GE,et al.Gender comparisonsin human lung cancer: analysis of p53 mutations,anti-p53 serum antibodies and C-erbB-2 expression[J].Carcinogenesis,1995,16(5):993-1002.
10Andrew M, Davidoff J,Dirk Igjehart, et al.Immune response to p53 is dependent upon p53/hsp70 complexes in breast cancers [J].Autoimmunity,1999,89(6):3439-3442.
二级参考文献17
1[1]Sinicrope FA,Ruan SB,Cleary KR,et al. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis [J]. Cancer Res, 1995,35(2) :237.
2[2]Ohue M,Tomita N,Monden T,et al. A frequent alteration of p53gene in carcinoma in adenoma of colon[J ]. Cancer Res, 1994, 54 (17) :4798.
3[3]Schlichtholz B,Legros Y,Gillet D,et al. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot [J]. Cancer Res, 1992,52(22) :6380.
4[4]Hammel P,Boissier B,Chaumette MT,et al. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer[J]. Gut, 1997,40(3) :356.
5[5]Angelopoulou K,Diamandis EP, Sutherland DJ, et al. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancer [J]. Int J Cancer, 1994,58 (4): 480.
6[1]Hollstein M, Sidransky D, Vagelstein B, et al. p53 mutations in human cancers. Science, 1991, 253:49～53
7[2]Sozzi G, Camey D. Molecular biology of lung cancer. Curr Opin Pulm Mod, 1998, 4(4): 207～212
8[3]Soussi T, Legros Y, Lubin R, et al. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer,1994, 57:1～9
9[4]Brambilla E,Brambilla C. p53 and lung cancer. Pathol Biol,1997, 45(10): 852～863
10[5]Lubin R, Schlichtholz B, Teillaud JL, et al. p53 antibodies in patients with various types of cancer assay, identification and characterization. Clin Cancer Res, 1995, 1:1463～1469
4Sangrajrang S,Sompmm A,Chemrungmj G,et al. Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking [J]. Lung Cancer, 2003,39 (3) : 297- 301.
5Chang F,Syrjanen S,Syrjanen K,et al.Implications of the p53 Tumour-suppressor Gene in Clinical Oncology[J].J Clin Oncol,1995,13(4):1009-1022.
6Crawford L V,Pim D C,Bulbrook R,et al.Dectection of Antibodies Against the Cellular p53 in Sera from Patient with Breast Cancers[J].Int J Cancer,1982,30(2):403-408.
7Wunderlich H,Hindermann W,Huller M,et al.The Correlation of p53 Protein Over-expression and p53 Antibodies in Serum of Patients with Transitional Cell Carcinoma of the Urinary Bladder[J].Urol Int,2003,64(3):13-17.
8Zhang Yan.Serum p53 Antibody and Lung Cancer[J].Oncol Fas Fore Med,2000,27:170.
9Sakai H,Okamoto E.Clinical Importance of Serum Anti-p53 Antibodies as Tumor Markers[J].Rinsho Byori,2002,50(10):970-975.
10Hogdall E V,Hogdall C K,Bladkaer J.p53 Auto-antibodies in Sera from Danish Ovarian Cancer Patients and their Correlation with Clinical Data and Prognosis[J].APMIS,2002,110(7/8):545-553.
